PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Bishai, William R.
TI  - New Issues in the Management of MDR/XDR-TB
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 23--24
VI  - 12
IP  - 14
4099  - http://mdc.sagepub.com/content/12/14/23.short
4100  - http://mdc.sagepub.com/content/12/14/23.full
AB  - In 2008 Dr. Michael D. Iseman of National Jewish Health said, “In roughly 55 years we have squandered our precious legacy of chemotherapy for…tuberculosis [TB].” William R. Bishai, MD, PhD, Director of the The KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa, echoed this idea, saying that “HIV and multidrug- resistant [MDR] strains of TB threaten to reverse a half century of partial control of TB.” He was referring to the TB and HIV coepidemics in sub-Saharan Africa.